| 发明名称 | Treatment of kidney fibrosis with VIP fragments | ||
| 摘要 | The invention relates to compositions comprising vasoactive intestinal peptide (VIP) or fragments thereof, and the use of such compositions in the treatment of kidney disease, in particular kidney fibrosis, and other associated conditions. | ||
| 申请公布号 | US9238054(B2) | 申请公布日期 | 2016.01.19 |
| 申请号 | US201314034706 | 申请日期 | 2013.09.24 |
| 申请人 | VECTUS BIOSYSTEMS PTY LIMITED | 发明人 | Duggan Karen Annette |
| 分类号 | A61K38/22;A61P13/12;C07K14/575;A61K38/10;A61K38/08;A61K38/00 | 主分类号 | A61K38/22 |
| 代理机构 | Wenderoth, Lind & Ponack, L.L.P. | 代理人 | Wenderoth, Lind & Ponack, L.L.P. |
| 主权项 | 1. A method of therapeutic treatment of kidney fibrosis in a subject, the method comprising administering to a subject having kidney fibrosis a composition comprising a pharmaceutically effective amount of one or more functional vasoactive intestinal peptide (VIP) fragments selected from VIP(10-28), VIP(6-10), VIP(6-12), VIP(6-16), VIP(6-20) and VIP(6-24), optionally in combination with a pharmaceutically acceptable carrier. | ||
| 地址 | Roseberry, New South Wales AU | ||